1. Japan Stocks

  2. •

    Commercial services

  3. •

    Miscellaneous commercial services
WDB coco Co., Ltd.

WDB coco Co., Ltd.

TTSE:7079
2,558.00
JPY
-10.00
(-0.39%)
6.24BMarket Cap
Nov 06Next Earn
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
641.95
890.85
1,100.39
1,123.6
1,529.07
1,703.73
1,912.06
2,215.02
2,002.53
- -
Basic EPS, GAAP
86.75
118.33
147.59
163.11
273.94
311.24
356.9
379.61
282.47
- -
Free Cash Flow per Basic Share
66.19
133
161.18
127.58
298.65
189.29
284.98
452.65
216.75
- -
Dividend per Share
35.01
51
61.14
33.91
34.96
39.98
41.01
75.02
80
- -
Book Value per Share
228.43
287.36
541.51
664.82
899.39
1,166.91
1,481.82
1,786.4
1,988.87
- -
Tangible Book Value per Share
228.43
287.36
541.51
664.82
893.72
1,154.15
1,382.39
1,698.72
1,915.26
- -
Basic Weighted Avg Shares
2
2
2
2
2
2
2
2
2
2
Sales/Revenue/Turnover
1,467
1,782
2,286
2,571
3,615
4,071
4,596
5,327
4,816
- -
Operating Margin (%)
20.26
18.98
20.72
20.41
26.65
26.67
27.7
24.52
19.88
- -
Depreciation Expense
1
3
9
11
18
32
33
56
57
- -
Net Income, GAAP
198
237
307
373
648
744
858
913
679
- -
Effective Tax Rate (%)
33.24
30.02
31.22
29.22
32.55
31.64
32.61
30.29
29.57
- -
Profit Margin (%)
13.51
13.28
13.41
14.52
17.92
18.27
18.67
17.14
14.11
- -
Working Capital
490
633
1,104
1,449
1,903
2,329
3,132
3,815
4,331
- -
LT Debt
- -
2
5
14
22
13
14
17
55
- -
Total Equity
522
657
1,237
1,571
2,148
2,803
3,564
4,296
4,783
- -
Return on Invested Capital (%)
- -
33.61
29.57
23.18
29.79
25.96
24.24
21
13.97
- -
Return on Capital (%)
- -
40.05
32.19
26.32
34.34
29.7
26.74
23.07
14.79
- -
Return on Common Equity (%)
- -
40.16
32.37
26.58
34.83
30.04
26.95
23.23
14.96
- -

Capital Structure

JPY

•

in mil. unless spec.
Sep'26
Mar'26
Jun'27
ST Debt
- -
25
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
55
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
2
2
2
Market Capitalization
6,459
6,241
6,168

Working Capital

JPY

•

in mil. unless spec.
Sep'26
Mar'26
Jun'27
Total Current Assets
4,653
4,967
- -
Cash, Cash Equivalents & STI
3,502
3,762
- -
Accounts Receivable, Net
1,098
1,159
- -
Inventories
4
2
- -
Total Current Liabilities
708
636
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
25
- -
Deferred Revenue
- -
- -
- -

Growth Rates

JPY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
25.25%
11.33%
Free Cash Flow
- -
32.84%
-52.12%
Net Income, GAAP
- -
16.91%
-25.59%
Sales/Revenue/Turnover
- -
14.49%
-9.59%
Total Cash Common Dividend
- -
22.99%
6.64%

Quarterly Revenue

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
5,327
2026
- -
- -
- -
- -
4,816
2027
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
379.61
2026
- -
- -
- -
- -
282.47
2027
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
75.02
2026
- -
- -
- -
- -
80
2027
- -
- -
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Haruhiko Taniguchi
Full Time Employees
516
Sector
Commercial services
Industry
Miscellaneous commercial services
Address
Triton Square Y Tokyo TY Japan 104-6127
IPO Date
Dec 25, 2019
Website
wdbcoco.com
Similar Companies
PayPal Holdings, Inc. (NASDAQ:PYPL)
Shopify Inc. (NASDAQ:SHOP)
Greenland Mines Ltd (NASDAQ:GRML)
Block, Inc. (NYSE:XYZ)
Netcapital Inc. (NASDAQ:NCPL)
Shopify, Inc. Class A (TSX:SHOP)
Business
WDB coco Co., Ltd. WDB coco Co., Ltd. (7079:TYO) provides contract research organization services primarily focused on safety information management, post-marketing surveillance, and clinical research support for the development of pharmaceuticals and medical devices in Japan. The company offers pharmacovigilance services including safety information management support; post-marketing surveillance operations such as contract conclusion with medical facilities, survey explanations, receipt of survey forms, monitoring, re-surveys, case registration, data management, and statistical analysis; clinical research support and monitoring; support for clinical trials, regulatory affairs, and quality assurance including dossier preparation for product registration, translation, and QC; medical devices development assistance; and temporary staffing or manpower dispatch services. Incorporated in 1984 and headquartered in Tokyo, Japan, at Triton Square Y 27F, 1-8-11 Harumi, Chuo-ku, WDB coco operates four branches domestically and leverages proprietary IT systems and know-how to deliver high-quality, low-cost one-stop solutions for post-marketing and clinical processes, targeting pharmaceutical companies and related sectors. As a subsidiary within the WDB Holdings Co., Ltd. group, it collaborates with affiliates like Cobridge Co., Ltd. for regulatory consulting and Oy Medfiles Ltd. for European and US market support in clinical trials and pharmacovigilance. Recent activities emphasize expansion through group synergies for global operations with hubs in Japan and Finland, alongside standardization and automation of operations to enhance efficiency, though no major acquisitions, funding rounds, or new product launches are reported in the past 1-2 years.